Comerica Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$232K Sell
531
-38
-7% -$18.9K 0.02% 411
2023
Q2
$286K Buy
569
+48
+9% +$23K 0.02% 386
2023
Q1
$261K Buy
521
+13
+3% +$6.22K 0.02% 409
2022
Q4
$207K Buy
+508
New +$197K 0.01% 463
2022
Q2
Sell
-446
Closed -$244K 484
2022
Q1
$244K Buy
446
+22
+5% +$11.6K 0.02% 435
2021
Q4
$279K Buy
424
+42
+11% +$26.4K 0.02% 434
2021
Q3
$238K Sell
382
-94
-20% -$63.2K 0.02% 458
2021
Q2
$301K Sell
476
-258
-35% -$142K 0.02% 404
2021
Q1
$359K Sell
734
-116
-14% -$58.1K 0.03% 378
2020
Q4
$425K Buy
850
+30
+4% +$13.4K 0.03% 318
2020
Q3
$322K Buy
820
+90
+12% +$33.3K 0.03% 340
2020
Q2
$241K Buy
+730
New +$211K 0.02% 374

Other funds holding IDXX

Comerica Securities's IDXX Position: Q3 2023 in Review

Comerica Securities reduced its Idexx Laboratories (IDXX) stake by 6.7% in Q3 2023, selling an estimated $18.9K and leaving 531 shares worth $232K. The position accounts for 0.02% of the portfolio, ranked #411.

Comerica Securities first reported a position in IDXX in Q2 2020 and has held it in 12 quarters since. The position peaked at $425K in Q4 2020. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Comerica Securities held 531 shares of Idexx Laboratories worth $232K as of Q3 2023.
  • Comerica Securities sold 38 Idexx Laboratories shares in Q3 2023, an estimated $18.9K.
  • Idexx Laboratories made up 0.02% of Comerica Securities's portfolio in Q3 2023, its #411 holding.
  • Comerica Securities first reported a position in Idexx Laboratories in Q2 2020 and has held it in 12 quarters since.
  • Comerica Securities's Idexx Laboratories position peaked at $425K in Q4 2020.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.